AFreeze is a medical device company dedicated to improve the treatment for patients with cardiac arrythmias. Our products are designed to improve patient’s lives and their health.
With deep ties to the Medical University of Innsbruck and the UMIT - Private University of Health Sciences, Medical Informatics and Technology, the scientific concept behind AFreeze’s products emerged in the mid-2000 years.
By using cryoenergy to induce distinct lesions in coronary heart tissue, a safe, well tolerated treatment option for cardiac arrhythmias can be established. AFreeze’s flagship product is the [email protected] cryoablation system for the treatment of atrial fibrillation. It is a safe, efficient and very easy to use device, designed to simplify the catheter ablation procedure and to improve the therapeutic outcome for atrial fibrillation.